Gastrodin reduces tau hyperphosphorylation in 3xTg‐AD mice, reverses decreased brain matrix viscoelasticity, and remodels ECM components by targeting the Alzheimer's risk gene FERMT2, primarily in astrocytes. Here, FERMT2 is linked to Alzheimer disease.